1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CNS PHARMACEUTICALS INC
Cns Pharmaceuticals Inc
XNAS: CNSP
Download real time
7.84 5.53 (239.39%)
77.47% Fall from 52W High
83.3M
XNAS Volume
High volume+gain today

XNAS 04 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Cns Pharma Inc is on 15 May 2026 for the purpose of CNS Pharmaceuticals Inc First Quarter Earnings Results for 2026 See details


Insider Trading disclosures for Cns Pharma Inc

The latest disclosure was made by Eric Faulkner in Cns Pharma Inc where a trade of 9,500 Restricted Stock Units done was reported to US exchanges on March 2, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Eric Faulkner Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2026 9,500 9,500 - - Restricted Stock Units
Rami Levin Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2026 19,000 19,000 - - Restricted Stock Units
Jeffry R. Keyes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Nov 2025 1,517 1,517 - - Option to purchase common stock
John M. Climaco Director, Chief Executive Officer 17 Nov 2025 9,761 9,761 - - Option to purchase common stock
Christopher S. Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Nov 2025 4,881 4,881 - - Option to purchase common stock
Faith L. Charles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Nov 2025 1,517 1,517 - - Option to purchase common stock
Jerzy Gumulka Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Nov 2025 1,517 1,517 - - Option to purchase common stock
Bettina M. Cockroft Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Nov 2025 1,517 1,517 - - Option to purchase common stock
Amy Mahery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Nov 2025 1,517 1,517 - - Option to purchase common stock
Faith L. Charles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 17,500 47,315 - - Option to purchase common stock
John M. Climaco Director, Chief Executive Officer 08 Apr 2024 83,000 559,533 - - Restricted Stock Units
John M. Climaco Director, Chief Executive Officer 08 Apr 2024 83,000 476,533 - - Option to purchase common stock
Jeffry R. Keyes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 17,500 62,928 - - Option to purchase common stock
Jeffry R. Keyes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 17,500 80,428 - - Restricted Stock Units
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 40,000 241 - - Restricted Stock Units
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 40,000 201 - - Option to purchase common stock
Faith L. Charles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 17,500 64,815 - - Restricted Stock Units
Jerzy Gumulka Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 17,500 129,594 - - Option to purchase common stock
Carl Evans Director 08 Apr 2024 17,500 147,094 - - Restricted Stock Units
Carl Evans Director 08 Apr 2024 17,500 129,594 - - Option to purchase common stock
Bettina M. Cockroft Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 17,500 35,574 - - Option to purchase common stock
Bettina M. Cockroft Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 17,500 53,074 - - Restricted Stock Units
Amy Mahery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 17,500 47,420 - - Restricted Stock Units
Amy Mahery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 17,500 29,920 - - Option to purchase common stock
Jerzy Gumulka Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2024 17,500 147,594 - - Restricted Stock Units
M. John Climaco Director, Chief Executive Officer 01 Feb 2024 166,666 393,533 - - Series B Warrant to purchase common stock
Carl Evans Director 01 Feb 2024 33,333 33,458 (0%) 0% 0.3 10,000 Common stock
John M. Climaco Director, Chief Executive Officer 01 Feb 2024 166,666 215,676 (1%) 1% 0.3 50,000 Common stock
Gumulka Jerzy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 33,333 78,761 - - Series A Warrant to purchase common stock
Downs Christopher Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.30 per share. 01 Feb 2024 66,666 103,438 (0%) 0% 0.3 20,000 Common stock
Downs Christopher Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 66,666 94,906 - - Series A Warrant to purchase common stock
M. John Climaco Director, Chief Executive Officer 01 Feb 2024 166,666 226,867 - - Series A Warrant to purchase common stock
Mahery Amy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 12,420 12,420 - - Option to purchase common stock
Gumulka Jerzy Director Purchase of securities on an exchange or from another person at price $ 0.30 per share. 01 Feb 2024 33,333 43,006 (0%) 0% 0.3 10,000 Common stock
Downs Christopher Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 66,666 161,572 - - Series B Warrant to purchase common stock
Evans Carl Director 01 Feb 2024 33,333 112,094 - - Series B Warrant to purchase common stock
Gumulka Jerzy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 33,333 112,094 - - Series B Warrant to purchase common stock
Carl Evans Director 01 Feb 2024 33,333 78,761 - - Series A Warrant to purchase common stock
Christopher Downs Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.27 per share. 22 Aug 2023 27,000 36,772 (0%) 0% 1.3 34,177 Common Stock
John M. Climaco Director, Chief Executive Officer 16 Aug 2023 2,750 49,010 (0%) 0% 1.8 4,945 Common Stock
Bettina M. Cockroft Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2023 2,099 2,099 - - Option to purchase common stock
Christopher Downs Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2023 521 9,772 (0%) 0% - Common Stock
John M. Climaco Director, Chief Executive Officer 28 Apr 2023 1,250 60,201 - - Restricted Stock Units
John M. Climaco Director, Chief Executive Officer 28 Apr 2023 1,250 46,260 (0%) 0% - Common Stock
Christopher Downs Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2023 521 28,248 - - Restricted Stock Units
Jerzy Gumulka Director Purchase of securities on an exchange or from another person at price $ 1.70 per share. 19 Apr 2023 2,500 9,673 (0%) 0% 1.7 4,250 Common Stock
Christopher Downs Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.20 per share. 17 Apr 2023 3,100 9,251 (0%) 0% 3.2 9,920 Common Stock
John M. Climaco Director, Chief Executive Officer 12 Apr 2023 15,000 45,010 (0%) 0% 0.7 10,409 Common Stock
Jerzy Gumulka Director Purchase of securities on an exchange or from another person at price $ 0.74 per share. 10 Apr 2023 7,173 7,173 (0%) 0% 0.7 5,308 Common Stock
John M. Climaco Director, Chief Executive Officer 29 Mar 2023 16,467 61,451 - - Restricted Stock Units
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2023 6,067 28,768 - - Restricted Stock Units
Faith L. Charles Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2022 3,500 3,500 - - Option to purchase common stock
John M. Climaco Director, Chief Executive Officer 28 Apr 2022 600,000 1,349,500 - - Restricted Stock Units
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2022 250,000 681,000 - - Restricted Stock Units
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.31 per share. 11 Mar 2022 33,000 184,500 (1%) 0% 0.3 10,230 Common Stock
Carl Evans Director 08 Mar 2022 3,750 3,750 (0%) 0% 0.3 1,005 Common Stock
John M. Climaco Director, Chief Executive Officer 07 Mar 2022 35,000 940,298 (5%) 0% 0.3 9,835 Common Stock
Jeffry R. Keyes Director Grant, award, or other acquisition of securities at price $ 0.30 per share. 07 Mar 2022 11,100 11,100 (0%) 0% 0.3 3,294 Common Stock
Christopher Downs Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.94 per share. 06 Dec 2021 5,000 151,500 (0%) 0% 0.9 4,702 Common Stock
Christopher Downs Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.15 per share. 19 Nov 2021 4,500 146,500 (0%) 0% 1.2 5,192 Common Stock
John M. Climaco Director, Chief Executive Officer 16 Nov 2021 5,000 905,298 (5%) 0% 1.3 6,400 Common Stock
Jeffry R. Keyes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2021 32,000 178,559 - - Option to purchase common stock
Jerzy Gumulka Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2021 32,000 178,559 - - Option to purchase common stock
Andrzej Andraczke Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2021 32,000 178,559 - - Option to purchase common stock
Carl Evans Director 15 Jul 2021 32,000 178,559 - - Option to purchase common stock
John M. Climaco Director, Chief Executive Officer 05 Feb 2021 310,000 749,500 - - Option to purchase common stock (right to buy)
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2021 131,000 431,000 - - Option to purchase common stock (right to buy)
Christopher Downs Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.04 per share. 24 Aug 2020 142,000 142,000 (0%) 0% 2.0 289,680 Common Stock
Carl Evans None 12 Jun 2020 46,559 146,559 - - Option to purchase common stock
Andrzej Andraczke None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2020 46,559 146,559 - - Option to purchase common stock
Jerzy Gumulka None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2020 46,559 146,559 - - Option to purchase common stock
Jeffry R. Keyes None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2020 46,559 146,559 - - Option to purchase common stock
Christopher Downs Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2019 300,000 300,000 - - Option to purchase common stock (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters